Augmedix has raised $78.0M in total across 5 funding rounds.
Augmedix's investors include Mangrove Capital Partners, Partech Ventures, 111° West Capital, Addition, B Capital Group, Canaan Partners, Emergence Capital, Fifth Wall, Flare Capital Partners, Great Oaks Venture Capital, HealthQuest Capital, IPD Capital.
Augmedix is a technology company specializing in ambient AI-driven medical documentation solutions designed to capture and convert clinician-patient conversations into real-time, structured medical notes integrated directly into electronic health records (EHRs)**. It primarily serves hospitals, health systems, physician practices, and telemedicine providers, aiming to reduce clinicians' administrative burdens, improve documentation accuracy, and enhance patient care experiences. Augmedix’s product suite includes offerings like Augmedix Live, which combines ambient AI with trained medical documentation specialists for synchronous support, and Augmedix Go, a self-service AI scribe for asynchronous note generation. The company leverages advanced technologies such as Automatic Speech Recognition (ASR), Natural Language Processing (NLP), and specialty-specific Large Language Models (LLMs) to deliver accurate, timely clinical notes[1][2][3][4].
Founded in 2012 in San Francisco, Augmedix emerged from the vision to humanize healthcare by reducing the time clinicians spend on electronic documentation, thus allowing them to focus more on patient interaction. The founders recognized the inefficiencies and burnout caused by EHR documentation and sought to create a seamless ambient scribing solution. Early adoption involved the innovative use of Google Glass to enable remote scribes to capture clinical encounters, a pioneering approach that helped establish Augmedix as a leader in ambient medical documentation. Over time, the company evolved its technology beyond wearable devices to a broader AI-powered platform, culminating in its acquisition by Commure in October 2024, which expanded its capabilities and market reach[1][6][8].
Augmedix rides the growing trend of ambient intelligence and AI automation in healthcare, addressing the critical challenge of clinician burnout caused by extensive EHR documentation. The timing is favorable due to increasing healthcare digitization, regulatory pressures to improve documentation quality, and the expanding telehealth market. By automating documentation, Augmedix helps healthcare providers increase efficiency, improve patient engagement, and reduce costs. Its approach also contributes to the broader ecosystem by enabling data-driven insights from millions of clinician-patient interactions, which can inform quality improvement and population health management[1][2][3].
Looking ahead, Augmedix is positioned to deepen its integration of advanced AI technologies, including more sophisticated NLP and predictive analytics, to further streamline clinical workflows and enhance decision support. The company’s acquisition by Commure suggests a strategic expansion into broader healthcare software infrastructure, potentially enabling more comprehensive digital health solutions. Trends such as increased adoption of telemedicine, value-based care models, and AI-driven clinical insights will likely shape Augmedix’s growth trajectory and influence. Its continued focus on reducing clinician burden while improving documentation quality will remain central to its impact on healthcare delivery[1][2][8].
Augmedix has raised $78.0M across 5 funding rounds. Most recently, it raised $19.0M Series B in October 2019.
